Clinical Trial Update: Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating fibroblast growth factor-2 (FGF-2) for periodontal tissue regeneration in periodontitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Fibroblast Growth Factor-2 (FGF-2)

Snippet

Sponsor: Kaken Pharmaceutical | Conditions: Periodontitis | Phase 2 | Status: COMPLETED